Everything below concerns c-Met signaling. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-07-21. Numbers and descriptions here follow the published literature rather than marketing material.
Dihexa is a synthetic peptidomimetic derived from angiotensin IV, a naturally occurring peptide fragment. It was created as a research compound to explore central nervous system signaling rather than as an approved therapeutic. Early work described it as a small, orally available molecule in rodent studies. Its structure combines tyrosine, isoleucine, and aminohexanoic acid components with a hexanoic acid cap. The compound is commonly referred to by the research code PNB-0408.
Development of dihexa followed from studies on angiotensin IV analogs and their effects on learning and memory. Researchers sought compounds with improved metabolic stability and brain penetration compared with natural peptides. In preclinical reports, dihexa was associated with changes in synaptic connectivity and performance on spatial tasks. These findings generated interest in its potential as a cognitive research tool. The work remains largely preclinical, and independent replication has been limited.
The proposed mechanism of dihexa involves activation of hepatocyte growth factor and its receptor, c-Met. In cell models, this signaling pathway is associated with dendritic spine formation and synaptic reorganization. Dihexa is described as a stabilized analog of angiotensin IV, which also interacts with related systems. However, the precise binding profile and downstream effects remain incompletely characterized. Most mechanistic evidence comes from in vitro assays and rodent studies rather than human trials.
Laboratory characterization of dihexa typically relies on reverse-phase high-performance liquid chromatography for purity and mass spectrometry for identity. These methods are standard for synthetic peptides and help distinguish the target compound from related impurities or degradation products. Because dihexa is a small peptide-like molecule, it may be susceptible to hydrolysis under certain conditions. Storage recommendations generally emphasize low temperature, dryness, and protection from light. Analytical certificates from suppliers vary in detail, so independent verification can be important for research use.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic angiotensin IV analog | Peptidomimetic |
| Appearance | White to off-white powder | Lyophilized solid |
| Solubility | Soluble in DMSO; limited in water | Typical for small peptides |
| Storage | -20 °C, desiccated | Protect from light and moisture |
| Analytical method | HPLC with UV detection | Purity and identity checks |
Dissolution depends on the peptide’s salt form, purity, and the chosen solvent. Dimethyl sulfoxide is commonly used to prepare concentrated stock solutions, while aqueous buffers may show limited solubility. Sonication or gentle warming can sometimes aid dissolution, but excessive heat may promote degradation. Once in solution, the material is generally kept cold and protected from light. Researchers should verify solubility for each lot rather than assuming uniform behavior across suppliers.
Quality control usually combines reverse-phase high-performance liquid chromatography with mass spectrometry. Chromatography estimates purity and detects related impurities, while mass spectrometry supports molecular identity. Nuclear magnetic resonance can provide additional structural confirmation when needed. Stability data for dihexa are limited, and degradation pathways may depend on pH, temperature, and moisture. Open questions include long-term stability in different formulations and the effect of repeated freeze-thaw cycles on measured purity. Such tests help confirm that a batch matches its label before use.
Chemically, dihexa belongs to a broader group of angiotensin IV analogs. Researchers have modified the natural peptide to alter stability, binding, or distribution. Such changes can affect how the molecule behaves in experiments. The parent peptide angiotensin IV is involved in various physiological processes, but the modified analog is not identical to it. Public summaries sometimes blur the distinction between the natural fragment and the synthetic research compound. This distinction matters when interpreting study results.
Dihexa is a synthetic peptide that has been examined in laboratory and animal research. Its design is based on angiotensin IV, a naturally occurring peptide fragment produced in the body. The short name dihexa appears in scientific papers and online discussions, while the full chemical name describes a modified peptide chain. It is not a vitamin, mineral, or plant-derived compound. Suppliers typically present it as a research chemical rather than an approved medicine.
The full name often given is N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. This name indicates a chain containing tyrosine, isoleucine, and a six-carbon amino acid derivative. Databases list a CAS Registry Number and a molecular formula for the compound. The peptide is small compared with proteins, and its structure allows it to be studied in cell cultures and animal models. Exact identity depends on the supplier's synthesis and purification process. Minor impurities can remain after synthesis.
RNA therapeutics are a new class of medications based on ribonucleic acid (RNA). Research has been working on clinical use since the 1990s, with significant success in cancer therapy in the early 2010s. In 2020 and 2021, mRNA vaccines have been developed globally for use in combating the coronavirus disease (COVID-19 pandemic). The Pfizer–BioNTech COVID-19 vaccine was the first mRNA vaccine approved by a medicines regulator, followed by the Moderna COVID-19 vaccine, and others. The main types of RNA therapeutics are those based on messenger RNA (mRNA), antisense RNA (asRNA), RNA interference (RNAi), RNA activation (RNAa) and RNA aptamers. Of the four types, mRNA-based therapy is the only type which is based on triggering synthesis of proteins within cells, making it particularly useful in vaccine development. Antisense RNA is complementary to coding mRNA and is used to trigger mRNA inactivation to prevent the mRNA from being used in protein translation. RNAi-based systems use a similar mechanism, and involve the use of both small interfering RNA (siRNA) and micro RNA (miRNA) to prevent mRNA translation and/or degrade mRNA. Small activating RNA (saRNA) represents a novel class of RNA therapeutics that upregulates gene expression via the RNAa mechanism, offering a unique mechanism compared to other RNA-based therapies. However, RNA aptamers are short, single stranded RNA molecules produced by directed evolution to bind to a variety of biomolecular targets with high affinity thereby affecting their normal in vivo activity.
Molybdenum forms chemical compounds in oxidation states −4 and from −2 to +6. Higher oxidation states are more relevant to its terrestrial occurrence and its biological roles, mid-level oxidation states are often associated with metal clusters, and very low oxidation states are typically associated with organomolybdenum compounds. The chemistry of molybdenum and tungsten show strong similarities. The relative rarity of molybdenum(III), for example, contrasts with the pervasiveness of the chromium(III) compounds. The highest oxidation state is seen in molybdenum(VI) oxide (MoO3), whereas the normal sulfur compound is molybdenum disulfide MoS2.
=== Christmas bombings === On 14 December 1972, Nixon sent an ultimatum demanding that Tho return to Paris to "negotiate seriously" within 72 hours or else he would bomb North Vietnam without limit. Knowing that Nixon was considering sacking him, Kissinger approved of his decision to resume bombing North Vietnam. Kissinger told the media that while the peace agreement was "99 percent completed…we will not be blackmailed into an agreement. We will not be stampeded into an agreement and, if I may say so, we will not be charmed into an agreement until its conditions are right". At the same time, Nixon ordered Admiral Thomas Hinman Moorer, the Chairman of the Joint Chiefs of Staff: "I don't want any more of this crap about the fact that we couldn't hit this target or that one. This is your chance to use military power to win this war, and if you don't, I'll hold you responsible". Following the rejection of Nixon's ultimatum, on 18 December, Operation Linebacker II was launched, the so-called Christmas Bombings that lasted until 29 December 1972. During these 11 days of bombing that were the heaviest bombing of the entire war, B-52 bombers flew 3,000 sorties and dropped 40,000 tons of bombs on Hanoi and Haiphong. About 1,261 people were killed in Hanoi and another 305 in Haiphong, as the North Vietnamese authorities had pulled out most people from the two cities beforehand to escape the expected bombings.
Sources: en.wikipedia.org
T-tubules are microscopic tubes that run from the cell surface to deep within the cell. They are continuous with the cell membrane, are composed of the same phospholipid bilayer, and are open at the cell surface to the extracellular fluid that surrounds the cell. T-tubules in cardiac muscle are bigger and wider than those in skeletal muscle, but fewer in number. In the centre of the cell they join, running into and along the cell as a transverse-axial network. Inside the cell they lie close to the cell's internal calcium store, the sarcoplasmic reticulum. Here, a single tubule pairs with part of the sarcoplasmic reticulum, called a terminal cisterna, in a combination known as a diad. The functions of T-tubules include rapidly transmitting electrical impulses known as action potentials from the cell surface to the cell's core, and helping to regulate the concentration of calcium within the cell in a process known as excitation-contraction coupling. They are also involved in mechano-electric feedback, as evident from cell contraction induced T-tubular content exchange (advection-assisted diffusion), which was confirmed by confocal and 3D electron tomography observations.
=== Non-Levantine groups claiming Israelite ancestry === Largely owing to the spread of Christianity and Islam globally, several groups of people outside of the Levant have claimed Israelite ancestry on an ethnic or racial basis. These various non-Levantine groups include Mandaeans, Pashtuns, British Israelists, Black Hebrew Israelites, Igbos, Mormons, and the Christian Identity movement. The phenomenon became especially prevalent after the founding of the State of Israel in 1948, as the country's Law of Return grants citizenship to qualified Jews and to non-Jews who are either married to a Jew or provide sufficient evidence of having Jewish ancestry.
== Pharmacology == Infliximab is a purified, recombinant DNA-derived chimeric human-mouse IgG monoclonal antibody that consists of mouse heavy and light chain variable regions combined with human heavy and light chain constant regions. It has a serum half-life of 9.5 days and can be detected in serum 8 weeks after infusion treatment. Infliximab neutralizes the biological activity of TNF by binding with high affinity to the soluble (free floating in the blood) and transmembrane (located on the outer membranes of T cells and similar immune cells) forms of TNF, and inhibits or prevents the effective binding of TNF with its receptors. Infliximab and adalimumab (another TNF antagonist) are in the subclass of "anti-TNF antibodies" (they are in the form of naturally occurring antibodies), and are capable of neutralizing all forms (extracellular-, transmembrane-, and receptor-bound) of TNF. Etanercept, a third TNF antagonist, is in a different subclass (receptor-construct fusion protein), and, because of its modified form, cannot neutralize receptor-bound TNF. Additionally, the anti-TNF antibodies adalimumab and infliximab have the capability of lysing cells involved in the inflammatory process, whereas the receptor fusion protein apparently lacks this capability. Other monoclonal antibodies targeting TNF are golimumab, adalimumab, and certolizumab pegol. Etanercept also binds and inhibits the action of TNF, but is not a monoclonal antibody (it is instead a fusion of TNF-receptor and an antibody constant region).
==== Gene function prediction ==== While genome annotation is primarily based on sequence similarity (and thus homology), other properties of sequences can be used to predict the function of genes. In fact, most gene function prediction methods focus on protein sequences as they are more informative and more feature-rich. For instance, the distribution of hydrophobic amino acids predicts transmembrane segments in proteins. However, protein function prediction can also use external information such as gene (or protein) expression data, protein structure, or protein–protein interactions.
Sources: en.wikipedia.org
The Chanka people lived in the Huancavelica, Ayacucho, and Apurímac regions of Peru. The Huanca people of the Junín Region of Peru spoke Quechua before the Incas did. The Inca established the largest empire of the pre-Columbian era. The Chincha, an extinct merchant kingdom of the Chincha Islands of Peru. The Qolla inhabited the Potosí, Oruro, and La Paz departments of Bolivia. The Cañari of Ecuador adopted the Quechua language from the Inca. The speakers of Quechua total some 5.1 million people in Peru, 1.8 million in Bolivia, 2.5 million in Ecuador (Hornberger and King, 2001), and according to Ethnologue (2006) 33,800 in Chile, 55,500 in Argentina, and a few hundred in Brazil. Only a slight sense of common identity exists among these speakers spread all over Peru, Bolivia and Ecuador. The various Quechua dialects are in some cases so different from one another that mutual understanding is not possible. Quechua was spoken not only by the Incas, but also by long-term enemies of the Inca Empire, including the Huanca (Wanka is a Quechua dialect spoken today in the Huancayo area) and the Chanka (the Chanca dialect of Ayacucho) of Peru, and the Kañari (Cañari) in Ecuador. Quechua was spoken by some of these people, for example, the Wanka, before the Incas of Cusco, while other people, especially in Bolivia but also in Ecuador, adopted Quechua only in Inca times or afterward. Some Christian organizations also refer to a "Quechua people", such as the Christian shortwave radio station HCJB, "The Voice of the Andes" (La Voz de los Andes).
== Distribution and habitat == Vanilla planifolia is a native of the neotropical realm, from southern Mexico through Central America, Colombia, and the northern portions of Brazil. Previously it had been thought to be native to just southern Mexico and Belize. Because of cultivation, V. planifolia has additionally spread to tropical areas across the world, primarily in south Florida, the Cayman Islands, the Dominican Republic, Jamaica, Puerto Rico, tropical portions of Peru, Ecuador, Venezuela, French Guiana, Suriname, and Guyana in the Americas, but also the Democratic Republic of the Congo, Madagascar, Comoros, Bangladesh, the Malay Peninsula, the island of Java, the Chagos Archipelago, Cook Island, New Guinea, and New Caledonia. Vanilla planifolia requires a humid, warm tropical climate and grows best between 20 and 30 °C (68 and 86 °F) in humid conditions. It can only accept a minimum of 10 °C (50 °F) and a maximum of 33 °C (91 °F). Minimum rainfall requirements are about 2000 mm per year. For good growth it prefers well-draining soils with a pH between 6.0 and 7.0 and plenty of available calcium and potassium. The natural altitude range is from 150 to 900 meters. To trigger flowering it requires a dry period in the spring. Due to human land uses for crops and timber the required habitat for Vanilla planifolia has become very reduced and fragmented. The number of mature individuals in the wild is declining and the amount of suitable habitat also continues to decline. The IUCN formally assessed the species as Endangered in 2017, publishing their assessment in 2020.
=== 2010 === On February 3, 2010, David A. Larson, an elected official in California who has a relationship with government contract personnel, made disclosures to the U.S. Department of Defense (DOD), Office of the Inspector General (OIG) alleging that under the Bush Administration, prisoners detained at Abu Ghraib, Guantanamo Bay, and undisclosed "black sites" were being used as involuntary research subjects for human biomedical experimentation, behavior modification research, and drug-testosterone delivery in a manner similar to past CIA Project MKULTRA activities investigated in 1977 by Senators Kennedy and Inuoye. The allegation supports information contained in an International Red Cross report relative to the expanded role of CIA medical personnel in torture and interrogation.
=== Vitamin k metabolism === The enzyme is also involved in biosynthetic processes such as the vitamin K-dependent gamma-carboxylation of glutamate residues in prothrombin synthesis. NQO1 catalyzes the reduction of vitamin K1, K2 and K3 into their hydroquinone form, but it only has a high affinity for Vitamin K3. Vitamin K hydroquinone serves as a cofactor for vitamin K γ‐carboxylase that catalyzes γ‐carboxylation of specific glutamic acid residues in Gla‐factors/proteins (Gla domain) leading to their activation and participation in blood clotting and bone metabolism. Vitamin K is used as radiation sensitizer or in mixtures with other chemotherapeutic drugs to treat several types of cancer. ROS generated in redox cycling contributes to anticancer activity of vitamin K. NQO1 competes with enzymes that redox cycle vitamin K to formation of semiquinone and ROS. NQO1is therefore able to detoxify vitamin K3 and protect cells against oxidative stress.
== Side effects == Protriptyline shares side effects common to all TCAs. The most frequent of these are dry mouth, constipation, urinary retention, increased heart rate, sedation, irritability, decreased coordination, anxiety, blood disorders, confusion, decreased libido, dizziness, flushing, headache, impotence, insomnia, low blood pressure, nightmares, rapid or irregular heartbeat, rash, seizures, sensitivity to sunlight, stomach and intestinal problems. Other more complicated side effects include; chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling; sudden numbness or weakness, especially on one side of the body; sudden headache, confusion, problems with vision, speech, or balance; hallucinations, or seizure (convulsions); easy bruising or bleeding, unusual weakness; restless muscle movements in your eyes, tongue, jaw, or neck; urinating less than usual or not at all; extreme thirst with headache, nausea, vomiting, and weakness; or feeling light-headed or fainting. Dry mouth, if severe to the point of causing difficulty speaking or swallowing, may be managed by dosage reduction or temporary discontinuation of the drug. Patients may also chew sugarless gum or suck on sugarless candy in order to increase the flow of saliva. Some artificial saliva products may give temporary relief. Men with prostate enlargement who take protriptyline may be especially likely to have problems with urinary retention. Symptoms include having difficulty starting a urine flow and more difficulty than usual passing urine.
Sources: en.wikipedia.org
Dihexa is a synthetic peptidomimetic related to angiotensin IV. It is studied in preclinical research for effects on synaptic signaling and cognition. It is not an approved medication.
No major drug regulatory agency has approved dihexa for human use. Published human clinical trials are absent, so its safety and efficacy are not established. It is commonly sold for laboratory research only.
It was developed from research on angiotensin IV analogs and peptide stability. The goal was to find compounds with better brain penetration and metabolic resistance. Early studies used rodent models rather than human participants.
Dihexa has been reported to activate hepatocyte growth factor/c-Met signaling in cell studies. This pathway is linked to synapse formation and neuronal remodeling. The exact molecular interactions are not fully understood.